Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001929063 | SCV002204332 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2023-04-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002507590 | SCV002815143 | uncertain significance | Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV | 2022-05-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003348634 | SCV004067261 | uncertain significance | Inborn genetic diseases | 2023-06-30 | criteria provided, single submitter | clinical testing | The c.6245G>A (p.R2082Q) alteration is located in exon 35 (coding exon 34) of the CACNA1H gene. This alteration results from a G to A substitution at nucleotide position 6245, causing the arginine (R) at amino acid position 2082 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |